As one of the prognostic biomarkers in the treatment of breast cancer, the Ki-67 index has been demonstrated to be associated with tumour chemosensitivity and associated with a more frequent pCR, while pCR improves patient survival [2]. This evidence concerns the gene MKI67 and breast carcinoma.